alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1

                                                                EXHIBIT 10.18(b)

                    AMENDMENT #1 TO THE EMPLOYMENT AGREEMENT
                                    BETWEEN
                          INTROGEN THERAPEUTICS, INC.
                                      AND
                                 DAVID G. NANCE

         Introgen Therapeutics, Inc. ("Company") and David G. Nance
("Employee") hereby agree to the following amendments to the Employment
Agreement dated August 1, 1996, between Company and Employee, which Amendments
shall be effective as of August 1, 1998:

         Paragraph 2 is deleted and replaced with the following new Paragraph 2:

         "2. TERM OF AGREEMENT. The initial term of employment (the "Term")
         shall commence on the date written above and end on July 31, 1999,
         provided that, unless either party gives written notice that this
         Agreement will not be renewed to the other party more than thirty (30)
         days prior to expiration of any then existing term of this Agreement,
         then upon expiration of such term this Agreement shall be automatically
         renewed for an additional term of one year. Such automatic renewals
         shall continue annually from year to year until either party timely
         gives notice of non-renewal as provided above, or until this Agreement
         otherwise terminates pursuant to the provisions of Paragraph 7 or 8
         hereof."

         The portion of the first sentence of Paragraph 3 that precedes the
first semi-colon of that sentence is deleted and replaced with the following
wording:

         "3. COMPENSATION, BASE SALARY. During the Employment Term, Employee
         shall receive a minimum aggregate base salary at the rate of $275,000
         per annum, or any such greater amount as may be approved by the Board
         of Directors of the Company from time to time;"

         The parties have executed this Amendment #1 effective August 1, 1998.


                                 COMPANY:

                                 INTROGEN THERAPEUTICS, INC.

                                 By: /s/ John N. Kapoor
                                    ------------------------------
                                     John N. Kapoor, Chairman


                                 EMPLOYEE:

                                     /s/ David G. Nance
                                    ------------------------------
                                     David G. Nance
II 

112TH CONGRESS 

1ST SESSION S. 1374 

To direct the Federal Trade Commission to prescribe rules prohibiting 

deceptive advertising of abortion services. 

IN THE SENATE OF THE UNITED STATES 

JULY 14, 2011 

Mr. MENENDEZ introduced the following bill; which was read twice and 

referred to the Committee on Commerce, Science, and Transportation 

A BILL 

To direct the Federal Trade Commission to prescribe rules 

prohibiting deceptive advertising of abortion services. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Stop Deceptive Adver5 tising for Women’s Services Act’’. 

6 SEC. 2. PROHIBITION OF DECEPTIVE ADVERTISING OF 

7 ABORTION SERVICES. 

8 (a) CONDUCT PROHIBITED.—Not later than 180 

9 days after the date of enactment of this Act, the Federal 

10 Trade Commission shall promulgate rules to prohibit, as 


jlentini on DSK4TPTVN1PROD with BILLS
2 

•S 1374 IS

1 an unfair and deceptive act or practice, any person from 

2 advertising with the intent to deceptively create the im3 pression that— 

4 (1) such person is a provider of abortion serv5 ices if such person does not provide abortion serv6 ices; and 

7 (2) such person is not a provider of abortion 

8 services if such person does provide abortion serv9 ices. 

10 (b) ENFORCEMENT.—The Federal Trade Commis11 sion shall enforce the rules required under subsection (a) 

12 as if a violation of such rules were a violation of section 

13 5(a)(1) of the Federal Trade Commission Act (15 U.S.C. 

14 45(a)(1)). The Commission shall enforce such rules in the 

15 same manner and by the same means, powers, and duties 

16 as though all applicable terms and provisions of the Fed17 eral Trade Commission Act were incorporated into and 

18 made a part of this Act. 

19 SEC. 3. DEFINITIONS. 

20 For purposes of the rules prescribed under section 

21 2, the following definitions apply: 

22 (1) ADVERTISE.—The term ‘‘advertise’’ means 

23 offering of goods or services to the public, regardless 

24 of whether such goods or services are offered for 

25 payment or result in a profit. 


jlentini on DSK4TPTVN1PROD with BILLS
3 

•S 1374 IS

1 (2) ABORTION SERVICES.—The term ‘‘abortion 

2 services’’ means providing surgical and non-surgical 

3 procedures to terminate a pregnancy, or providing 

4 referrals for such procedures. 

5 (3) PERSON.—The term ‘‘person’’ has the 

6 meaning given such term in section 551(2) of title 

7 5, United States Code. 

Æ 


jlentini on DSK4TPTVN1PROD with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention 

*Correction:*                     This notice was published in the                     **Federal Register**                     on April 9, 2007, Volume 72, Number 67, page 17555. The meeting was originally scheduled as a teleconference. In lieu of a                           ( print page 21266)                        teleconference, the SEP will now convene at the Doubletree Hotel, 3342 Peachtree Road, NE., Atlanta, GA 30326.                 

*Date and Time:*                     8:30 a.m.-3 p.m., May 10, 2007.                 

*Contact Person for More Information:*                     Juliana Cyril, M.P.H., PhD, Associate Director for Policy and Peer Review, CDC, 1600 Clifton Road, NE., Mailstop D-72, Atlanta, GA 30333, Telephone (404) 639-3098.                 

                    The Director, Management Analysis and Services Office, has been delegated the authority to sign                     **Federal Register**                     notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.                 

Dated: April 25, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.   

[FR Doc. E7-8248 Filed 4-27-07; 8:45 am] 

BILLING CODE 4163-18-P
<TABLE> <S> <C>

<ARTICLE>           5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          30,677
<SECURITIES>                                         0
<RECEIVABLES>                                   82,986
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               117,979
<PP&E>                                          93,914
<DEPRECIATION>                                 (91,971)
<TOTAL-ASSETS>                                 148,067
<CURRENT-LIABILITIES>                          118,066
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   148,067
<SALES>                                              0
<TOTAL-REVENUES>                               836,513
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 1,431
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              11,526
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             (8,041)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
#### Lisa M. KRUSE, Petitioner, v. OFFICE OF PERSONNEL MANAGEMENT, Respondent.

No. 05-3289.

United States Court of Appeals, Federal Circuit.

Aug. 23, 2005.

Lisa M. Kruse, Marla T. Conneely, pro se.

ORDER

The petitioner having failed to pay the docketing fee required by Federal Circuit Rule 52(a)(1) within the time permitted by the rules, it is

ORDERED that the petition for review be, and the same hereby is, DISMISSED, for failure to prosecute in accordance with the rules.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Agriculture

###### Agricultural Research Service 

# AGENCY:

Agricultural Research Service, USDA. 

# ACTION:

Notice of intent. 

# SUMMARY:

Notice is hereby given that the U.S. Department of Agriculture, Agricultural Research Service, intends to grant to Antibacterial Resources, Inc. of El Paso, Texas, an exclusive license to U.S. Patent No. 5,656,037, “Reaction Products of Magnesium Acetate and Hydrogen Peroxide for Imparting Antibacterial Activity to Fibrous Substrates”, issued on August 12, 1997. 

      ( print page 24266)    

# DATES:

Comments must be received by June 1, 2007. 

# ADDRESSES:

Send comments to: USDA, ARS, Office of Technology Transfer, 5601 Sunnyside Avenue, Rm. 4-1174, Beltsville, Maryland 20705-5131. 

# FOR FURTHER INFORMATION CONTACT:

June Blalock of the Office of Technology Transfer at the Beltsville address given above; telephone: 301-504-5989. 

# SUPPLEMENTARY INFORMATION:

The Federal Government's patent rights in this invention are assigned to the United States of America, as represented by the Secretary of Agriculture. It is in the public interest to so license this invention as Antibacterial Resources, Inc. of El Paso, Texas has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within thirty (30) days from the date of this published Notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. 

Richard J. Brenner, 

Assistant Administrator. 

 [FR Doc. E7-8365 Filed 5-1-07; 8:45 am] 

BILLING CODE 3410-03-P
#### George McLachlan & Sons, Inc. *v.*United States

No. 6803.

Entry No. 700332.

Invoice dated London, England, April 1945.

Certified May 1945.

Entered at New York, N. Y., July 6, 1945.

(Decided January 23, 1947)

*John D. Rode*for the plaintiff.

*Paul P. Rao,*Assistant Attorney General, for the defendant.

Ekwall, Judge:

This appeal for reappraisement has been submitted for decision upon the following stipulation of counsel for the parties hereto:

(Stipulation omitted.)

On the agreed facts I find the export value, as that value is defined in section 402 (d) of the Tariff Act of 1930, to be the proper basis for the determination of the value of the merchandise here involved, and that such values are the appraised values, less the additions made by the importer on entry because of advances by the appraiser in similar cases.

Judgment will be rendered accordingly.
NASA LogoNTRSNTRS - NASA Technical Reports ServerSearchmore_vertCollectionsAboutNewsHelpLogin Back to ResultsKilopower Reactor Using Stirling TechnologY (KRUSTY) Nuclear Ground Test Results and Lessons LearnedThe Kilopower nuclear ground testing nicknamed KRUSTY (Kilopower Reactor Using Stirling TechnologY) was completed at the Nevada Nuclear Security Site (NNSS) on March 21, 2018. This full scale nuclear demonstration verified the Kilopower reactor neutronics during startup, steady state, and transient operations in a space simulated environment. This was the first space reactor test completed for fission power systems in over 50 years and marked a turning point in NASA's nuclear program. The completed reactor power system design incorporated flight prototypic materials and full-scale components in an effort to study the reactor dynamics at full power and significantly reduce follow on risk of a future flight demonstration. This design provided a unique opportunity for the power system to simulate several nominal and off-nominal mission scenarios that allowed the designers to verify that the reactor dynamics could tolerate many worst case conditions regarding reactor stability and control. The dynamic changes imposed on the reactor validated the ability of the reactor to load follow the power conversion system and passively control the fuel temperature and overall system stability. With successful completion of the KRUSTY experiment, the NASA/DOE team will evaluate the lessons learned throughout the project and apply them towards a flight demonstration of a Kilopower reactor.Document ID20180007389Acquisition SourceGlenn Research CenterDocument TypeTechnical Memorandum (TM)AuthorsGibson, Marc A.*(NASA Glenn Research Center Cleveland, OH, United States)*Poston, David I.*(Los Alamos National Lab. Los Alamos, NM, United States)*McClure, Patrick*(Los Alamos National Lab. Los Alamos, NM, United States)*Godfroy, Thomas J.*(Vantage Partners, LLC Brook Park, OH, United States)*Briggs, Maxwell H.*(NASA Glenn Research Center Cleveland, OH, United States)*Sanzi, James L.*(Vantage Partners, LLC Brook Park, OH, United States)*Date AcquiredNovember 1, 2018Publication DateOctober 1, 2018Subject CategorySpacecraft Propulsion And PowerReport/Patent NumberNASA/TM-2018-219941E-19555GRC-E-DAA-TN58624Funding Number(s)WBS: WBS 469947.04.23.22CONTRACT_GRANT: NNC14IA02ICONTRACT_GRANT: NNC12BA01BDistribution LimitsPublicCopyrightPublic Use Permitted.Available DownloadsNameType20180007389.pdfSTIcloud_downloadcontent_copyvisibilityRelated RecordsIDRelationTitle20180005435See AlsoThe Kilopower Reactor Using Stirling TechnologY (KRUSTY) Nuclear Ground Test Results and Lessons Learnedvisibility_offNo Preview Available
 No Fear Act | Freedom of Information Act | Office of the Inspector General | Agency Financial ReportsNASA Web Privacy Policy and Important Notices | NASA Guidelines for Quality of InformationDisclaimers, Copyright, Terms of Use | Accessibility | NASA OCIO | USA.gov | NASA.govContact Us | Site MapSTI LogoNASA Official: JoAnne R. Calhoun Site Curator: STI Compliance and Distribution Services Last Modified: September 12, 2024
[Federal Register Volume 72, Number 87 (Monday, May 7, 2007)]
[Notices]
[Page 25788]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-8658]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-247]


Entergy Nuclear Operations, Inc.; Notice of Withdrawal of 
Application for Amendment to Facility Operating License

    The U.S. Nuclear Regulatory Commission (the Commission) has granted 
the request of Entergy Nuclear Operations, Inc. (the licensee) to 
withdraw its July 10, 2006, application for proposed amendment to 
Facility Operating License No. DPR-26 for Indian Point Nuclear 
Generating Unit No. 2, located in Westchester County, New York.
    The proposed amendment would have revised the Technical 
Specifications pertaining to spent fuel cask loading operations.
    The Commission had previously issued a Notice of Consideration of 
Issuance of Amendment published in the Federal Register on August 29, 
2006 (71 FR 51227). However, by letter dated April 11, 2007, the 
licensee withdrew the proposed change.
    For further details with respect to this action, see the 
application for amendment dated July 10, 2006, and the licensee's 
letter dated April 11, 2007, which withdrew the application for license 
amendment. Documents may be examined, and/or copied for a fee, at the 
NRC's Public Document Room (PDR), located at One White Flint North, 
Public File Area O1 F21, 11555 Rockville Pike (first floor), Rockville, 
Maryland. Publicly available records will be accessible electronically 
from the Agencywide Documents Access and Management System (ADAMS) 
Public Electronic Reading Room on the internet at the NRC Web site, 
http://www.nrc.gov/reading-rm.html. Persons who do not have access to 
ADAMS or who encounter problems in accessing the documents located in 
ADAMS should contact the NRC PDR Reference staff by telephone at 1-800-
397-4209, or 301-415-4737 or by e-mail to <a href="/cdn-cgi/l/email-protection#88f8ecfac8e6faeba6efe7fe"><span class="__cf_email__" data-cfemail="becedaccfed0ccdd90d9d1c8">[email protected]</span></a>.

     Dated at Rockville, Maryland, this 1st day of May 2007.

    For the Nuclear Regulatory Commission.
John P. Boska,
Senior Project Manager, Plant Licensing Branch I-1, Division of 
Operating Reactor Licensing, Office of Nuclear Reactor Regulation.
 [FR Doc. E7-8658 Filed 5-4-07; 8:45 am]
BILLING CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
---

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO SECTION 906 
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Xiangqian Li, the Chief Executive Officer of CHINA BAK BATTERY, INC. (the Company), DOES HEREBY CERTIFY that:

1. The Companys Quarterly Report on Form 10-Q for the quarter ended December 31, 2010 (the Report), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

IN WITNESS WHEREOF, each of the undersigned has executed this statement this 9th day of February, 2011.

/s/ Xiangqian LiXiangqian Li 
Chief Executive Officer (Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to China BAK Battery, Inc. and will be retained by China BAK Battery, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

The forgoing certification is being furnished to the Securities and Exchange Commission pursuant to § 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

---
(Reap. Dec. 9423)

#### United China & Glass Co. *v.*United States

Entry Nos. C.E. *731;*C.E. 24164.

(Decided May 12, 1959)

*Stein & Shostak*for the plaintiff.

*George Cochran Douh,*Assistant Attorney General, for the defendant.

Wilson, Judge:

This appeal for reappraisement has been submitted for decision upon the following stipulation of counsel for the respective parties hereto:

> IT IS HEREBY STIPULATED AND AGREED by and between counsel for the respective parties hereto, subject to the approval of the Court, as to the merchandise covered by the above entitled appeal for reappraisement, which is also set out in Schedule A, attached hereto and made a part hereof, that at the time of exportation of the instant merchandise to the United States, the prices at which such or similar merchandise was freely offered for sale to all purchasers in the principal market of the country from which exported, in the usual wholesale quantities and in the ordinary course of trade, for export to the United States, including the cost of all containers and coverings of whatever nature, and all other costs, charges and expenses incident to placing the merchandise in condition, packed ready for shipment to the United States, were the invoiced and entered values, ex factory, and that there were no higher foreign values for such or similar merchandise at the time of exportation.

> IT IS FURTHER STIPULATED AND AGREED that this appeal for reap-praisement may be deemed submitted for decision on this stipulation.

On the agreed facts, I find the export value, as that value is defined in section 402(d) of the Tariff Act of 1930, to be the proper basis for the determination of the value of the merchandise here involved and that such value in each case was the invoiced and entered value.

Judgment will be entered accordingly.
IN THE SUPREME COURT OF PENNSYLVANIA

EASTERN DISTRICT

F.A. REALTY INVESTORS CORP.

v.

BOARD OF REVISION OF TAXES

PETITION OF: STEVE A. FREMPONG :

:

:

:

:

:

:

:

:

: No. 404 EAL 2019

Petition for Allowance of Appeal from

the Order of the Commonwealth

Court

ORDER

PER CURIAM

AND NOW , this 4th day of February, 2020

, the Petition for Allowance of Appeal is

DENIED

.
Before the First Division,

March 4, 1942

No. 46996.

#### Protests 913804-G, etc., of E. E. Holler (Nogales).

*475Opinion by

Oliver, P. J.

It was stipulated between counsel that the fish livers in question are similar to those the subject of Abstracts 38801 and 38915. In accordance therewith the claim for free entry under paragraph 1669 was sustained.